Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

849
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
849

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Assessment of Patient-Centered Content on Left Ventricular Assist Devices on US Hospital Webpages.

Circulation. Population health and outcomes·2026
Same author

Association of elective peripheral vascular intervention with outcomes among patients with peripheral arterial disease and intermittent claudication.

Journal of vascular surgery·2026
Same author

Coverage Limitations for Use of Urine Drug Testing in a State Medicaid Program.

JAMA network open·2026
Same author

From Registry to Reality: Opportunities to Enhance Post-market Surveillance of High-Risk Medical Devices Comment on "Quality and Utility of European Cardiovascular and Orthopaedic Registries for the Regulatory Evaluation of Medical Device Safety and Performance Across the Implant Lifecycle: A Systematic Review".

International journal of health policy and management·2026
Same author

Corporate Vectors of Chronic Disease - Using Internal Industry Documents to Craft Counterstrategies.

The New England journal of medicine·2026
Same author

Rapid cardioversion for acute atrial fibrillation.

BMJ (Clinical research ed.)·2025

関連する実験動画

Updated: May 5, 2026

A Modified Method for Heterotopic Mouse Heart Transplantion
11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 24, 2014

12.1K

Dhruva と Redberg の手紙 "心不全で入院した患者の間でのインプラント可能な心臓変圧器のカウンセリングと使用における性別と人種/民族の違い:ガイドライン-心不全プログラムからの発見"に関する記事

Sanket S Dhruva1, Rita F Redberg1

  • 1From Robert Wood Johnson Foundation Clinical Scholars Program, Yale University School of Medicine, New Haven, CT (S.S.D.); Cardiology, Veterans Affairs Connecticut Healthcare System, New Haven, CT (S.S.D.); and Department of Medicine, Division of Cardiology, University of California, San Francisco, CA (R.F.R.).

Circulation
|January 18, 2017
PubMed
まとめ

No abstract available in PubMed .

さらに関連する動画

Heterotopic Cervical Heart Transplantation in Mice
09:48

Heterotopic Cervical Heart Transplantation in Mice

Published on: August 25, 2015

11.2K
Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies
06:56

Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies

Published on: October 4, 2024

1.1K

関連する実験動画

Last Updated: May 5, 2026

A Modified Method for Heterotopic Mouse Heart Transplantion
11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 24, 2014

12.1K
Heterotopic Cervical Heart Transplantation in Mice
09:48

Heterotopic Cervical Heart Transplantation in Mice

Published on: August 25, 2015

11.2K
Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies
06:56

Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies

Published on: October 4, 2024

1.1K